These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23942101)

  • 1. Unfractionated heparin versus low-molecular-weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Ang E
    Clin Nurse Spec; 2013; 27(5):229-30. PubMed ID: 23942101
    [No Abstract]   [Full Text] [Related]  

  • 2. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?
    Warkentin TE; Greinacher A
    Chest; 2007 Oct; 132(4):1108-10. PubMed ID: 17934108
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparins--a safer option than unfractionated heparin?
    McKay GA; Paterson KR
    Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):256-76. PubMed ID: 11770172
    [No Abstract]   [Full Text] [Related]  

  • 4. Think of HIT when thrombosis follows heparin.
    Warkentin TE
    Chest; 2006 Sep; 130(3):631-2. PubMed ID: 16963651
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia in surgical patients.
    Battistelli S; Genovese A; Gori T
    Am J Surg; 2010 Jan; 199(1):43-51. PubMed ID: 20103065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of unfractionated heparin and low molecular weight heparins in pregnancy.
    Casele HL
    Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low-molecular-weight heparins versus unfractionated heparin for treatment of hemodialysed patients].
    Kes P; Basić-Jukić N; Jurić I
    Lijec Vjesn; 2007; 129(8-9):305-8. PubMed ID: 18198633
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of heparin-induced thrombocytopenia and thrombosis.
    Green RM
    Semin Vasc Surg; 1996 Dec; 9(4):292-5. PubMed ID: 8958605
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring and management of heparin-induced thrombocytopenia.
    Rogers B; Little Nj; Jones C
    Br J Hosp Med (Lond); 2009 Nov; 70(11):630-3. PubMed ID: 20081589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
    Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
    Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparins in the new millennium: will unfractionated heparin survive? Introduction.
    McClatchey KD; Galvin HM; Galvin RM
    Semin Thromb Hemost; 2000; 26 Suppl 1():3-4. PubMed ID: 11011801
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
    Roĭtman EV; Dement'eva II; Meshcheriakov AV
    Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
    Pohl C; Kredteck A; Bastians B; Hanfland P; Klockgether T; Harbrecht U
    Neurology; 2005 Apr; 64(7):1285-7. PubMed ID: 15824368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comment requested by the editorial staff].
    Haas S
    Chirurg; 2002 Dec; 73(12):1204. PubMed ID: 12617084
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fondaparinux treatment in heparin induced thrombocytopenia:a case report].
    Ozsu S; Korkmaz A; Bülbül Y; Oztuna F; Ozlü T
    Tuberk Toraks; 2011; 59(2):178-83. PubMed ID: 21740395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia.
    Bomzer CA
    N Engl J Med; 2001 Aug; 345(8):619; author reply 619-20. PubMed ID: 11529226
    [No Abstract]   [Full Text] [Related]  

  • 20. An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN.
    Schellong SM; Haas S; Greinacher A; Schwanebeck U; Sieder C; Abletshauser C; Bramlage P; Riess H
    Expert Opin Pharmacother; 2010 Dec; 11(18):2953-61. PubMed ID: 20950224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.